call Toll Free (US/Canada) : +1 866 658 6826 | call +1 425 320 4776 | call (UK) : +44 1865 60 0662 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Human Milk Oligosaccharides Market
Inquire Before Buying Request for Sample

Human Milk Oligosaccharides Market

Home Food And Beverages Human Milk Oligosaccharides Market

SPECIAL OFFER : 25% Super Discount For All !

Human Milk Oligosaccharides (HMO) Market - Size, Share, Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (2’FL, 3’FL, 3’SL, 6’SL); By Distribution Channel (Hypermarkets & Supermarkets, Drug Store or Pharmacy, Mass Merchandiser, Departmental Stores, Mono-brand Stores, Specialty Stores, Online Sales Channel, Others); By Application (Infant Formula, Functional Food & Beverages, Food Supplements, Health Ingredients, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published Date: April 2023
  • Report ID: BWC23330
  • Available Format: PDF
  • Page: 400

Report Overview

Increasing adoption of technology advancements, such as such as microbial fermentation, enzymatic synthesis, and chemical synthesis, in the production of Human Milk Oligosaccharides (HMO); and growing awareness about the benefits of HMOs in infant nutrition, including supporting digestive health are expected to boost the growth of global Human Milk Oligosaccharides (HMO) market during the forecast period between 2023 and 2029.

Global Human Milk Oligosaccharides (HMO) Market - Industry Trends & Forecast Report, 2029

Global Human Milk Oligosaccharides (HMO) market size was estimated to be worth USD 199 million in 2022. During the forecast period between 2023 and 2029, the global Human Milk Oligosaccharides (HMO) market size is projected to grow at a CAGR of 22.90% reaching a value of USD 842.78 million by 2029. Major growth factors for the global Human Milk Oligosaccharides (HMO) market include its rising use as an ingredient in infant formula and expansion of R&D activities. The availability of innovative technologies, such as enzymatic trans-glycosylation, which is utilized to artificially synthesize the HMOs, is one of the main drivers boosting the growth of human milk oligosaccharides (HMO) market.

Human Milk Oligosaccharides (HMO) Market

Global Human Milk Oligosaccharides (HMO) Market – Overview

Human milk oligosaccharides (HMOs) are a group of complex carbohydrates and the third most prevalent solid substance in human milk after lipids and lactose. Mother's milk contains HMOs that are essential for the immune system and intestinal barrier development in a newborn. Some HMOs may also have an impact on how the infant's brain develops. Although there are more than 100 distinct kinds of HMOs, most moms' breast milk contains the most 2'-FL HMO (2'-fucosyllactose), which is the most common form.

Global Human Milk Oligosaccharides (HMO) Market

Growth Drivers

Growing Awareness about the Benefits of HMOs in Infant Nutrition

Human milk oligosaccharides (HMO) help the infant's immune system and microbiota grow. They defend against several illnesses and slow down their progression by functioning via a variety of methods. It has been demonstrated that they have antibacterial, antiviral, and anti-inflammatory properties. The low breastfeeding rate in several countries including the UK, Ireland, and the United States is offering significant growth opportunities for infant formula with human milk oligosaccharides (HMO) ingredients, propelling the overall market growth.

Restraints

Limited Availability of HMOs from Natural Sources

Products containing human milk oligosaccharides (HMO) are expensive as only a little amount of HMO can be produced by synthesizing a significant quantity of human milk. The production of human milk oligosaccharides requires a number of expensive and scarce chemicals and enzymes. This might be a significant issue limiting the worldwide market for human milk oligosaccharides (HMO).

Impact of COVID-19 on the Global Human Milk Oligosaccharides (HMO) Market

The market for Human Milk Oligosaccharides (HMO) was affected by the COVID-19 pandemic. Due to panic buying for at-home consumption during the early stages of the pandemic, the demand for HMOs soared during the lockdown. Because HMOs operate as an immunity booster, their sales increased during the pandemic as a result. However, restrictions on production activities and a shortage of labor also created a huge demand and supply gap that impacted the market revenue negatively in the later period of the COVID-19 outbreak. But it is estimated that the market will overall gain new opportunities owing to the rising health consciousness among consumers.

Global Human Milk Oligosaccharides (HMO) Market

Segmental Coverage

Global Human Milk Oligosaccharides (HMO) Market – By Type

Based on type, the global Human Milk Oligosaccharides (HMO) market is segmented into 2’FL, 3’FL, 3’SL, and 6’SL. The 2’FL HMO type accounts for the highest market share owing to its health benefits. The 2’FL HMO is a beneficial dietary supplement to minimize the risk of infection because it helps build the immune system and has anti-inflammatory qualities, which limit the risk of infection caused by microorganisms. As a result, it has high demand among food companies to be used as an effective ingredient in infant formula.

Global Human Milk Oligosaccharides (HMO) Market – By Distribution Channel

Based on the distribution channel, the global Human Milk Oligosaccharides (HMO) market is segmented into hypermarkets & supermarkets, drugstores or pharmacies, mass merchandisers, departmental stores, mono-brand stores, specialty stores, online sales channels, and others. The drugstores or pharmacies segment holds the highest share in the global human milk oligosaccharides (HMO) market. As drug stores and pharmacies generally operate around-the-clock, customers can always access the items, which acts as a major factor in driving its market growth.

Global Human Milk Oligosaccharides (HMO) Market – By Application

Based on application, the global Human Milk Oligosaccharides (HMO) market is segmented into infant formula, functional food & beverages, food supplements, health ingredients, and others. The infant formula segment accounts for the largest market share. These HMO supplements shield newborns against infection. Additionally, it helps gut health maintenance, protects them from prebiotic effects, and boosts cognition. Therefore, most infant formula-making food companies add this component into their products, due to which its demand is gaining traction in the market.

Human Milk Oligosaccharides (HMO) Market Share

Global Human Milk Oligosaccharides (HMO) Market – By Region

The in-depth research report on the global Human Milk Oligosaccharides (HMO) market covers many country-specific markets across the five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. Europe dominates the global Human Milk Oligosaccharides (HMO) market, with Germany likely playing a significant role in the growth of the European market. The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period due to the growing health awareness among consumers in the region.

Competitive Landscape

Major players operating in the global Human Milk Oligosaccharides (HMO) market include Abbott Laboratories, FrieslandCampina Domo, DuPont Nutrition & Health, Jennewein Biotechnologie GmbH, Glycom A/S, Nestle S.A., Inbiose NV, ZuChem Inc., InnoBio Ltd., Elicityl SA, TCI Chemicals (India) Pvt. Ltd., Medolac Laboratories, Glycosyn LLC, Glycosyn-Stanford JV LLC, and ProZomix Limited.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

  • In December 2022 – Kirin, a Japan-based integrated beverages company, announced the commencement of the first human milk oligosaccharides (HMO) production plant in Rayong Province, Thailand.

  • In December 2022 – FrieslandCampina, a Netherlands-based multinational dairy cooperative, secured 2’-fucosyllactose approval in Australia and New Zealand for use in infant milk formula.

Scope of the Report

Attributes

Details

Years Considered

Historical Data – 2019–2022

Base Year – 2022

Estimated Year – 2023

Forecast Period – 2023–2029

Facts Covered

Revenue in USD Million

Market Coverage

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Product/ Service Segmentation

Type, Distribution Channel, Application, Region

Key Players

Abbott Laboratories, FrieslandCampina Domo, DuPont Nutrition & Health, Jennewein Biotechnologie GmbH, Glycom A/S, Nestle S.A., Inbiose NV, ZuChem Inc., InnoBio Ltd., Elicityl SA, TCI Chemicals (India) Pvt. Ltd., Medolac Laboratories, Glycosyn LLC, Glycosyn-Stanford JV LLC, ProZomix Limited

 

 

By Type

  • 2’FL

  • 3’FL

  • 3’SL

  • 6’SL

By Distribution Channel

  • Hypermarkets & Supermarkets

  • Drug Stores or Pharmacies

  • Mass Merchandisers

  • Departmental Stores

  • Mono-brand Stores

  • Specialty Stores

  • Online Sales Channel

  • Others

By Application

  • Infant Formula

  • Functional Food & Beverages

  • Food Supplements

  • Health Ingredients

  • Others

By Region

  • North America

  • Europe

  • Asia Pacific (APAC)

  • Latin America (LATAM)

  • Middle East and Africa (MEA)

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Executive Summary
  3. Global Human Milk Oligosaccharides (HMO) Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
        1. Growing awareness about the benefits of HMOs in infant nutrition, including supporting digestive health
        2. Technological advancements in HMO production, such as microbial fermentation, enzymatic synthesis, and chemical synthesis
        3. Rising prevalence of infant health issues, such as diarrhea, constipation, and allergies
      2. Restraints
        1. Stringent regulatory frameworks and labeling requirements for Human Milk Oligosaccharides (HMO)
        2. Limited availability of HMOs from natural sources, as they are only found in human milk and can be difficult to extract and purify
      3. Opportunities
        1. Rising demand for natural and sustainable ingredients in food and beverage products
        2. Expansion of the global infant formula market, particularly in emerging markets
      4. Challenges
        1. Increasing competition from alternative sources of functional ingredients, such as probiotics, prebiotics, and vitamins
    3. Product Advancements/Recent Developments
    4. Regulatory Framework
    5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
  4. Global Human Milk Oligosaccharides (HMO) Market Overview
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share and Forecast
      1. By Type
        1. 2’FL
        2. 3’FL
        3. 3’SL
        4. 6’SL
      2. By Distribution Channel
        1. Hypermarkets & Supermarkets
        2. Drug Store or Pharmacy
        3. Mass Merchandiser
        4. Departmental Stores
        5. Mono-brand Stores
        6. Specialty Stores
        7. Online Sales Channel
        8. Others
      3. By Application
        1. Infant Formula
        2. Functional Food & Beverages
        3. Food Supplements
        4. Health Ingredients
        5. Others
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific (APAC)
        4. Latin America (LATAM)
        5. Middle East and Africa (MEA)
  5. North America Human Milk Oligosaccharides (HMO) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
      2. By Distribution Channel
      3. By Application
      4. By Country
        1. United States
          1. By Type
          2. By Distribution Channel
          3. By Application
        2. Canada
          1. By Type
          2. By Distribution Channel
          3. By Application
  6. Europe Human Milk Oligosaccharides (HMO) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
      2. By Distribution Channel
      3. By Application
      4. By Country
        1. Germany
          1. By Type
          2. By Distribution Channel
          3. By Application
        2. United Kingdom
          1. By Type
          2. By Distribution Channel
          3. By Application
        3. Italy
          1. By Type
          2. By Distribution Channel
          3. By Application
        4. France
          1. By Type
          2. By Distribution Channel
          3. By Application
        5. Spain
          1. By Type
          2. By Distribution Channel
          3. By Application
        6. Belgium
          1. By Type
          2. By Distribution Channel
          3. By Application
        7. Russia
          1. By Type
          2. By Distribution Channel
          3. By Application
        8. The Netherlands
          1. By Type
          2. By Distribution Channel
          3. By Application
        9. Rest of Europe
          1. By Type
          2. By Distribution Channel
          3. By Application
  7. Asia Pacific Human Milk Oligosaccharides (HMO) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
      2. By Distribution Channel
      3. By Application
      4. By Country
        1. China
          1. By Type
          2. By Distribution Channel
          3. By Application
        2. India
          1. By Type
          2. By Distribution Channel
          3. By Application
        3. Japan
          1. By Type
          2. By Distribution Channel
          3. By Application
        4. South Korea
          1. By Type
          2. By Distribution Channel
          3. By Application
        5. Australia & New Zealand
          1. By Type
          2. By Distribution Channel
          3. By Application
        6. Indonesia
          1. By Type
          2. By Distribution Channel
          3. By Application
        7. Malaysia
          1. By Type
          2. By Distribution Channel
          3. By Application
        8. Singapore
          1. By Type
          2. By Distribution Channel
          3. By Application
        9. Vietnam
          1. By Type
          2. By Distribution Channel
          3. By Application
        10. Rest of APAC
          1. By Type
          2. By Distribution Channel
          3. By Application
  8. Latin America Human Milk Oligosaccharides (HMO) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
      2. By Distribution Channel
      3. By Application
      4. By Country
        1. Brazil
          1. By Type
          2. By Distribution Channel
          3. By Application
        2. Mexico
          1. By Type
          2. By Distribution Channel
          3. By Application
        3. Argentina
          1. By Type
          2. By Distribution Channel
          3. By Application
        4. Peru
          1. By Type
          2. By Distribution Channel
          3. By Application
        5. Rest of LATAM
          1. By Type
          2. By Distribution Channel
          3. By Application
  9. Middle East & Africa Human Milk Oligosaccharides (HMO) Market
    1. Market Size & Forecast, 2019–2029
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Type
      2. By Distribution Channel
      3. By Application
      4. By Country
        1. Saudi Arabia
          1. By Type
          2. By Distribution Channel
          3. By Application
        2. UAE
          1. By Type
          2. By Distribution Channel
          3. By Application
        3. Qatar
          1. By Type
          2. By Distribution Channel
          3. By Application
        4. Kuwait
          1. By Type
          2. By Distribution Channel
          3. By Application
        5. South Africa
          1. By Type
          2. By Distribution Channel
          3. By Application
        6. Nigeria
          1. By Type
          2. By Distribution Channel
          3. By Application
        7. Algeria
          1. By Type
          2. By Distribution Channel
          3. By Application
        8. Rest of MEA
          1. By Type
          2. By Distribution Channel
          3. By Application
  10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Global Human Milk Oligosaccharides (HMO) Market Share Analysis, 2022
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
  11. Impact of Covid-19 on Global Human Milk Oligosaccharides (HMO) Market
  12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
    1. Abbott Laboratories
    2. FrieslandCampina Domo
    3. DuPont Nutrition & Health
    4. Jennewein Biotechnologie GmbH
    5. Glycom A/S
    6. Nestle S.A.
    7. Inbiose NV
    8. ZuChem Inc.
    9. InnoBio Ltd.
    10. Elicityl SA
    11. TCI Chemicals (India) Pvt. Ltd.
    12. Medolac Laboratories
    13. Glycosyn LLC
    14. Glycosyn-Stanford JV LLC
    15. ProZomix Limited
    16. Other Prominent Players
  13. Key Strategic Recommendations
  14. Research Methodology
    1.  Qualitative Research
      1.  Primary & Secondary Research
    2.  Quantitative Research
    3.  Market Breakdown & Data Triangulation
      1.  Secondary Research
      2.  Primary Research
    4.  Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

Figures

Figure 1       Global Human Milk Oligosaccharides (HMO) Market Segmentation

Figure 2       Global Human Milk Oligosaccharides (HMO) Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2022

Figure 4       Global Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 5       Global Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 6       Global Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 7       Global Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 8       Global Human Milk Oligosaccharides (HMO) Market Share, By Region, By Value, 2019–2029

Figure 9       North America Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 10     North America Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 11     North America Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 12     North America Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 13     North America Human Milk Oligosaccharides (HMO) Market Share, By Country, By Value, 2019–2029

Figure 14     United States Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 15     United States Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 16     United States Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 17     United States Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 18     Canada Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 19     Canada Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 20     Canada Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 21     Canada Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 22     Europe Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 23     Europe Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 24     Europe Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 25     Europe Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 26     Europe Human Milk Oligosaccharides (HMO) Market Share, By Country, By Value, 2019–2029

Figure 27     Germany Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 28     Germany Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 29     Germany Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 30     Germany Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 31     United Kingdom Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 32     United Kingdom Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 33     United Kingdom Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 34     United Kingdom Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 35     Italy Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 36     Italy Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 37     Italy Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 38     Italy Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 39     France Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 40     France Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 41     France Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 42     France Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 43     Spain Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 44     Spain Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 45     Spain Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 46     Spain Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 47     Belgium Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 48     Belgium Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 49     Belgium Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 50     Belgium Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 51     Russia Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 52     Russia Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 53     Russia Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 54     Russia Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 55     The Netherlands Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 56     The Netherlands Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 57     The Netherlands Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 58     The Netherlands Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 59     Rest of Europe Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 60     Rest of Europe Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 61     Rest of Europe Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 62     Rest of Europe Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 63     Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 64     Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 65     Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 66     Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 67     Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share, By Country, By Value, 2019–2029

Figure 68     China Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 69     China Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 70     China Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 71     China Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 72     India Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 73     India Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 74     India Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 75     India Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 76     Japan Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 77     Japan Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 78     Japan Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 79     Japan Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 80     South Korea Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 81     South Korea Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 82     South Korea Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 83     South Korea Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 84     Australia & New Zealand Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 85     Australia & New Zealand Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 86     Australia & New Zealand Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 87     Australia & New Zealand Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 88     Indonesia Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 89     Indonesia Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 90     Indonesia Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 91     Indonesia Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 92     Malaysia Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 93     Malaysia Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 94     Malaysia Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 95     Malaysia Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 96     Singapore Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 97     Singapore Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 98     Singapore Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 99     Singapore Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 100   Vietnam Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 101   Vietnam Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 102   Vietnam Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 103   Vietnam Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 104   Rest of APAC Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 105   Rest of APAC Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 106   Rest of APAC Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 107   Rest of APAC Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 108   Latin America Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 109   Latin America Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 110   Latin America Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 111   Latin America Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 112   Latin America Human Milk Oligosaccharides (HMO) Market Share, By Country, By Value, 2019–2029

Figure 113   Brazil Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 114   Brazil Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 115   Brazil Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 116   Brazil Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 117   Mexico Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 118   Mexico Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 119   Mexico Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 120   Mexico Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 121   Argentina Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 122   Argentina Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 123   Argentina Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 124   Argentina Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 125   Peru Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 126   Peru Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 127   Peru Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 128   Peru Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 129   Rest of LATAM Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 130   Rest of LATAM Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 131   Rest of LATAM Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 132   Rest of LATAM Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 133   Middle East & Africa Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 134   Middle East & Africa Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 135   Middle East & Africa Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 136   Middle East & Africa Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 137   Middle East & Africa Human Milk Oligosaccharides (HMO) Market Share, By Country, By Value, 2019–2029

Figure 138   Saudi Arabia Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 139   Saudi Arabia Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 140   Saudi Arabia Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 141   Saudi Arabia Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 142   UAE Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 143   UAE Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 144   UAE Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 145   UAE Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 146   Qatar Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 147   Qatar Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 148   Qatar Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 149   Qatar Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 150   Kuwait Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 151   Kuwait Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 152   Kuwait Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 153   Kuwait Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 154   South Africa Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 155   South Africa Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 156   South Africa Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 157   South Africa Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 158   Nigeria Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 159   Nigeria Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 160   Nigeria Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 161   Nigeria Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 162   Algeria Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 163   Algeria Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 164   Algeria Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 165   Algeria Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Figure 166   Rest of MEA Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Figure 167   Rest of MEA Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Figure 168   Rest of MEA Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Figure 169   Rest of MEA Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

 

List of Tables

Table 1 Global Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 2 Global Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 3 Global Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 4 Global Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 5 Global Human Milk Oligosaccharides (HMO) Market Share, By Region, By Value, 2019–2029

Table 6 North America Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 7 North America Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 8 North America Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 9 North America Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 10      North America Human Milk Oligosaccharides (HMO) Market Share, By Country, By Value, 2019–2029

Table 11      United States Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 12      United States Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 13      United States Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 14      United States Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 15      Canada Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 16      Canada Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 17      Canada Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 18      Canada Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 19      Europe Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 20      Europe Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 21      Europe Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 22      Europe Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 23      Europe Human Milk Oligosaccharides (HMO) Market Share, By Country, By Value, 2019–2029

Table 24      Germany Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 25      Germany Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 26      Germany Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 27      Germany Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 28      United Kingdom Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 29      United Kingdom Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 30      United Kingdom Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 31      United Kingdom Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 32      Italy Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 33      Italy Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 34      Italy Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 35      Italy Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 36      France Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 37      France Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 38      France Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 39      France Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 40      Spain Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 41      Spain Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 42      Spain Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 43      Spain Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 44      Belgium Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 45      Belgium Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 46      Belgium Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 47      Belgium Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 48      Russia Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 49      Russia Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 50      Russia Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 51      Russia Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 52      The Netherlands Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 53      The Netherlands Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 54      The Netherlands Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 55      The Netherlands Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 56      Rest of Europe Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 57      Rest of Europe Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 58      Rest of Europe Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 59      Rest of Europe Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 60      Asia-Pacific Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 61      Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 62      Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 63      Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 64      Asia-Pacific Human Milk Oligosaccharides (HMO) Market Share, By Country, By Value, 2019–2029

Table 65      China Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 66      China Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 67      China Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 68      China Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 69      India Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 70      India Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 71      India Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 72      India Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 73      Japan Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 74      Japan Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 75      Japan Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 76      Japan Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 77      South Korea Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 78      South Korea Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 79      South Korea Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 80      South Korea Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 81      Australia & New Zealand Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 82      Australia & New Zealand Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 83      Australia & New Zealand Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 84      Australia & New Zealand Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 85      Indonesia Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 86      Indonesia Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 87      Indonesia Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 88      Indonesia Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 89      Malaysia Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 90      Malaysia Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 91      Malaysia Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 92      Malaysia Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 93      Singapore Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 94      Singapore Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 95      Singapore Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 96      Singapore Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 97      Vietnam Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 98      Vietnam Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 99      Vietnam Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 100    Vietnam Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 101    Rest of APAC Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 102    Rest of APAC Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 103    Rest of APAC Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 104    Rest of APAC Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 105    Latin America Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 106    Latin America Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 107    Latin America Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 108    Latin America Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 109    Latin America Human Milk Oligosaccharides (HMO) Market Share, By Country, By Value, 2019–2029

Table 110    Brazil Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 111    Brazil Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 112    Brazil Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 113    Brazil Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 114    Mexico Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 115    Mexico Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 116    Mexico Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 117    Mexico Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 118    Argentina Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 119    Argentina Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 120    Argentina Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 121    Argentina Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 122    Peru Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 123    Peru Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 124    Peru Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 125    Peru Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 126    Rest of LATAM Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 127    Rest of LATAM Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 128    Rest of LATAM Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 129    Rest of LATAM Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 130    Middle East & Africa Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 131    Middle East & Africa Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 132    Middle East & Africa Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 133    Middle East & Africa Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 134    Middle East & Africa Human Milk Oligosaccharides (HMO) Market Share, By Country, By Value, 2019–2029

Table 135    Saudi Arabia Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 136    Saudi Arabia Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 137    Saudi Arabia Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 138    Saudi Arabia Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 139    UAE Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 140    UAE Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 141    UAE Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 142    UAE Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 143    Qatar Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 144    Qatar Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 145    Qatar Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 146    Qatar Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 147    Kuwait Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 148    Kuwait Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 149    Kuwait Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 150    Kuwait Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 151    South Africa Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 152    South Africa Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 153    South Africa Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 154    South Africa Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 155    Nigeria Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 156    Nigeria Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 157    Nigeria Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 158    Nigeria Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 159    Algeria Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 160    Algeria Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 161    Algeria Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 162    Algeria Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 163    Rest of MEA Human Milk Oligosaccharides (HMO) Market Size, By Value (USD Million), 2019–2029

Table 164    Rest of MEA Human Milk Oligosaccharides (HMO) Market Share, By Type, By Value, 2019–2029

Table 165    Rest of MEA Human Milk Oligosaccharides (HMO) Market Share, By Distribution Channel, By Value, 2019–2029

Table 166    Rest of MEA Human Milk Oligosaccharides (HMO) Market Share, By Application, By Value, 2019–2029

Table 167    Abbott Laboratories Company Overview

Table 168    Abbott Laboratories Financial Overview

Table 169    FrieslandCampina Domo Company Overview

Table 170    FrieslandCampina Domo Financial Overview

Table 171    DuPont Nutrition & Health Company Overview

Table 172    DuPont Nutrition & Health Financial Overview

Table 173    Jennewein Biotechnologie GmbH Company Overview

Table 174    Jennewein Biotechnologie GmbH Financial Overview

Table 175    Glycom A/S Company Overview

Table 176    Glycom A/S Financial Overview

Table 177    Nestle S.A. Company Overview

Table 178    Nestle S.A. Financial Overview

Table 179    Inbiose NV Company Overview

Table 180    Inbiose NV Financial Overview

Table 181    ZuChem Inc. Company Overview

Table 182    ZuChem Inc. Financial Overview

Table 183    InnoBio Ltd. Company Overview

Table 184    InnoBio Ltd. Financial Overview

Table 185    Elicityl SA Company Overview

Table 186    Elicityl SA Financial Overview

Table 187    TCI Chemicals (India) Pvt. Ltd. Company Overview

Table 188    TCI Chemicals (India) Pvt. Ltd. Financial Overview

Table 189    Medolac Laboratories Company Overview

Table 190    Medolac Laboratories Financial Overview

Table 191    Glycosyn LLC Company Overview

Table 192    Glycosyn LLC Financial Overview

Table 193    Glycosyn-Stanford JV LLC Company Overview

Table 194    Glycosyn-Stanford JV LLC Financial Overview

Table 195    ProZomix Limited Company Overview

Table 196    ProZomix Limited Financial Overview

Market Segmentation

No data available
No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

Ans: Asia Pacific is expected to grow at the fastest rate in Global Human Milk Oligosaccharides (HMO) Market during the forecast period between 2023 and 2029.
Ans: Major factors driving the growth of Global Human Milk Oligosaccharides (HMO) Market include rising demand for natural and sustainable ingredients in food and beverage products and expansion of the global infant formula market, particularly in emerging markets.
Ans: Global Human Milk Oligosaccharides (HMO) Market size was estimated at USD 199 million in 2022.
Ans: The infant formula segment held the highest market share in the Global Human Milk Oligosaccharides (HMO) Market by application.
Ans: Key players in Global Human Milk Oligosaccharides (HMO) Market include Abbott Laboratories, FrieslandCampina Domo, DuPont Nutrition & Health, Jennewein Biotechnologie GmbH, Glycom A/S, Nestle S.A., Inbiose NV, ZuChem Inc., InnoBio Ltd., Elicityl SA, TCI Chemicals (India) Pvt. Ltd., Medolac Laboratories, Glycosyn LLC, Glycosyn-Stanford JV LLC, and ProZomix Limited.